Table of Contents
ISRN Oncology
Volume 2012, Article ID 636379, 10 pages
http://dx.doi.org/10.5402/2012/636379
Research Article

The Impact of 18F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma

1Departments of Nuclear Medicine, St. James's Institute of Oncology, Leeds LS9 7TF, UK
2Departments of Clinical Oncology, St. James's Institute of Oncology, Leeds LS9 7TF, UK
3Departments of Clinical Radiology, St. James's Institute of Oncology, West Yorkshire, Leeds LS9 7TF, UK

Received 8 December 2011; Accepted 16 January 2012

Academic Editor: Y. Yamamoto

Copyright © 2012 Robin J. D. Prestwich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. W. M. Van Den Brekel, H. V. Stel, J. A. Castelijns et al., “Cervical lymph node metastasis: assessment of radiologic criteria,” Radiology, vol. 177, no. 2, pp. 379–384, 1990. View at Google Scholar · View at Scopus
  2. M. W. M. Van den Brekel, J. A. Castelijns, and G. B. Snow, “The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it?” American Journal of Neuroradiology, vol. 19, no. 4, pp. 695–700, 1998. View at Google Scholar · View at Scopus
  3. J. A. Woolgar, “The topography of cervical lymph node metastases revisited: the histological findings in 526 sides of neck dissection from 439 previously untreated patients,” International Journal of Oral and Maxillofacial Surgery, vol. 36, no. 3, pp. 219–225, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. M. Wide, D. W. White, J. A. Woolgar, J. S. Brown, E. D. Vaughan, and H. G. Lewis-Jones, “Magnetic resonance imaging in the assessment of cervical nodal metastasis in oral squamous cell carcinoma,” Clinical Radiology, vol. 54, no. 2, pp. 90–94, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. M. W. M. Van Den Brekel, J. A. Castelijns, H. V. Stel, R. P. Golding, C. J. L. Meyer, and G. B. Snow, “Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study,” European Archives of Oto-Rhino-Laryngology, vol. 250, no. 1, pp. 11–17, 1993. View at Google Scholar · View at Scopus
  6. M. H. Weiss, L. B. Harrison, and R. S. Isaacs, “Use of decision analysis in planning a management strategy for the stage NO neck,” Archives of Otolaryngology, vol. 120, no. 7, pp. 699–702, 1994. View at Google Scholar · View at Scopus
  7. J.-L. Lefebvre, D. Chevalier, B. Luboinski, A. Kirkpatrick, L. Collette, and T. Sahmoud, “Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial,” Journal of the National Cancer Institute, vol. 88, no. 13, pp. 890–899, 1996. View at Publisher · View at Google Scholar
  8. J. Corry, L. J. Peters, and D. Rischin, “Optimising the therapeutic ratio in head and neck cancer,” The Lancet Oncology, vol. 11, no. 3, pp. 287–291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E. G. C. Troost, D. A. X. Schinagl, J. Bussink, W. J. G. Oyen, and J. H. A. M. Kaanders, “Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours,” Radiotherapy and Oncology, vol. 96, no. 3, pp. 328–334, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. M. Nutting, J. P. Morden, K. J. Harrington et al., “Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial,” The Lancet Oncology, vol. 12, no. 2, pp. 127–136, 2011. View at Publisher · View at Google Scholar
  11. F. Y. Feng, H. M. Kim, T. H. Lyden et al., “Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 5, pp. 1289–1298, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. D. M. Cannon and N. Y. Lee, “Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 3, pp. 660–665, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. L. J. Peters, B. O'Sullivan, J. Giralt et al., “Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02,” Journal of Clinical Oncology, vol. 28, no. 18, pp. 2996–3001, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. O. Warburg, The Metabolism of Tumours, Constable, London, UK, 1930.
  15. D. L. Schwartz, H. A. Macapinlac, and R. S. Weber, “FDG-PET staging of head and neck cancer—can improved imaging lead to improved treatment?” Journal of the National Cancer Institute, vol. 100, no. 10, pp. 688–689, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. J. Bussink, C. M. L. van Herpen, J. H. A. M. Kaanders, and W. J. G. Oyen, “PET-CT for response assessment and treatment adaptation in head and neck cancer,” The Lancet Oncology, vol. 11, no. 7, pp. 661–669, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Dirix, V. Vandecaveye, F. De Keyzer, S. Stroobants, R. Hermans, and S. Nuyts, “Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with F18-FDG PET, F18-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI,” Journal of Nuclear Medicine, vol. 50, no. 7, pp. 1020–1027, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. H. Ng, T. C. Yen, C. T. Liao et al., “F18-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation,” Journal of Nuclear Medicine, vol. 46, no. 7, pp. 1136–1143, 2005. View at Google Scholar · View at Scopus
  19. S. Adams, R. P. Baum, T. Stuckensen, K. Bitter, and G. Hör, “Prospective comparison of F18-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer,” European Journal of Nuclear Medicine, vol. 25, no. 9, pp. 1255–1260, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. J. W. Fletcher, B. Djulbegovic, H. P. Soares et al., “Recommendations on the use of F18-FDG PET in oncology,” Journal of Nuclear Medicine, vol. 49, no. 3, pp. 480–508, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. J. Fleming, S. P. Smith Jr., C. M. Paul et al., “Impact of [F18]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients,” Laryngoscope, vol. 117, no. 7, pp. 1173–1179, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. Y. Yamazaki, M. Saitoh, K. I. Notani et al., “Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer,” Annals of Nuclear Medicine, vol. 22, no. 3, pp. 177–184, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. L. Roh, N. K. Yeo, J. S. Kim et al., “Utility of 2-[F18] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma,” Oral Oncology, vol. 43, no. 9, pp. 887–893, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. AJCC Cancer Staging Manual, Springer, New York, NY, USA, 6th edition, 2002.
  25. R. J. D. Prestwich, K. Kancherla, D. Colpan Oksuz et al., “A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer,” Radiation Oncology, vol. 5, article 121, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. J. A. Lee, “Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology,” Radiotherapy and Oncology, vol. 96, no. 3, pp. 302–307, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. A. X. Schinagl, A. L. Hoffmann, W. V. Vogel et al., “Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?” Radiotherapy and Oncology, vol. 91, no. 1, pp. 95–100, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. P. A. Kyzas, E. Evangelou, D. Denaxa-Kyza, and J. P. A. Ioannidis, “F18-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis,” Journal of the National Cancer Institute, vol. 100, no. 10, pp. 712–720, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. G. J. Kubicek, C. Champ, S. Fogh et al., “FDG-PET staging and importance of lymph node SUV in head and neck cancer,” Head and Neck Oncology, vol. 2, no. 1, article 19, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. http://www.acrin.org/TabID/569/Default.aspx.
  31. A. M. Scott, D. H. Gunawardana, D. Bartholomeusz, J. E. Ramshaw, and P. Lin, “PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study,” Journal of Nuclear Medicine, vol. 49, no. 10, pp. 1593–1600, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. Lonneux, M. Hamoir, H. Reychler et al., “Positron emission tomography with [F18]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study,” Journal of Clinical Oncology, vol. 28, no. 7, pp. 1190–1195, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. C. A. Connell, J. Corry, A. D. Milner et al., “Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma,” Head and Neck, vol. 29, no. 11, pp. 986–995, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. A. M. Zanation, D. K. Sutton, M. E. Couch, M. C. Weissler, W. W. Shockley, and C. G. Shores, “Use, accuracy, and implications for patient management of [F18]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors,” Laryngoscope, vol. 115, no. 7, pp. 1186–1190, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. P. K. Ha, A. Hdeib, D. Goldenberg et al., “The Role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma,” Archives of Otolaryngology—Head and Neck Surgery, vol. 132, no. 1, pp. 12–16, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. Gordin, M. Daitzchman, I. Doweck et al., “Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management,” Laryngoscope, vol. 116, no. 2, pp. 273–278, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. B. F. Branstetter, T. M. Blodgett, L. A. Zimmer et al., “Head and neck malignancy: is PET/CT more accurate than PET or CT alone?” Radiology, vol. 235, no. 2, pp. 580–586, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. R. Syed, J. B. Bomanji, N. Nagabhushan et al., “Impact of combined F18-FDG PET/CT in head and neck tumours,” British Journal of Cancer, vol. 92, no. 6, pp. 1046–1050, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. R. J. Prestwich, D. O. Öksüz, K. Dyker, C. Coyle, and M. Şen, “Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic stage IV head-and-neck squamous cell carcinomas,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 4, pp. e237–e243, 2011. View at Publisher · View at Google Scholar · View at PubMed
  40. W. A. Weber, “Use of PET for monitoring cancer therapy and for predicting outcome,” Journal of Nuclear Medicine, vol. 46, no. 6, pp. 983–995, 2005. View at Google Scholar · View at Scopus
  41. R. S. Rodrigues, F. A. Bozza, P. E. Christian et al., “Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck,” Journal of Nuclear Medicine, vol. 50, no. 8, pp. 1205–1213, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. A. A. K. Abdel Razek, N. Y. Soliman, S. Elkhamary, M. K. Alsharaway, and A. Tawfik, “Role of diffusion-weighted MR imaging in cervical lymphadenopathy,” European Radiology, vol. 16, no. 7, pp. 1468–1477, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. D. King, A. T. Ahuja, D. K. W. Yeung et al., “Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging,” Radiology, vol. 245, no. 3, pp. 806–813, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus